Normal vs cancer thyroid stem cells: The road to transformation

Oncogene

Volumn 35, Issue 7, 2016, Pages 805-815

  Zane, M ^a,b   Scavo, E ^a   Catalano, V ^a   Bonanno, M ^a   Todaro, M ^a   De Maria, R ^c   Stassi, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STEM CELL; CARCINOGENESIS; DNA MODIFICATION; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID CELL; CELL TRANSFORMATION; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASTIC STEM CELLS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84958636857     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.138     Document Type: Review

References (95)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006; 6: 292-306.
3. Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 2008; 113: 48-56.
4. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7: 569-580.
5. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 2000; 289: 1357-1360.
6. Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S et al. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 2007; 13: 1161-1170.
7. Lin RY. Thyroid cancer stem cells. Nat Rev Endocrinol 2011; 7: 609-616.
8. Gibelli B, El-Fattah A, Giugliano G, Proh M, Grosso E. Thyroid stem cells - danger or resource? Acta Otorhinolaryngol Ital 2009; 29: 290-295.
9. Takano T, Amino N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid 2005; 15: 432-438.
10. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009; 19: 1351-1361.
11. Sastre-Perona A, Santisteban P. Role of the wnt pathway in thyroid cancer. Front Endocrinol (Lausanne) 2012; 3: 31.
12. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 1999; 59: 1811-1815.
13. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005; 103: 2261-2268.
14. Hardin H, Montemayor-Garcia C, Lloyd RV. Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers. Hum Pathol 2013; 44: 1707-1713.
15. Nikiforova MN, Ciampi R, Salvatore G, Santoro M, Gandhi M, Knauf JA et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 2004; 209: 1-6.
16. Coclet J, Foureau F, Ketelbant P, Galand P, Dumont JE. Cell population kinetics in dog and human adult thyroid. Clin Endocrinol 1989; 31: 655-665.
17. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992; 72: 667-697.
18. Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology 2007; 148: 4251-4258.
19. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kakudo K. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 2006; 56: 240-245.
20. Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol 2007; 17: 233-240.
21. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 1994; 74: 748-766.
22. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137: 375-378.
23. Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells - old concepts, new insights. Cell Death Differ 2008; 15: 947-958.
24. Thomas D, Friedman S, Lin RY. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer 2008; 15: 51-58.
25. Inaba M, Yamashita YM. Asymmetric stem cell division: precision for robustness. Cell Stem Cell 2012; 11: 461-469.
26. Yamashita YM, Yuan H, Cheng J, Hunt AJ. Polarity in stem cell division: asymmetric stem cell division in tissue homeostasis. Cold Spring Harb Perspect Biol 2010; 2: a001313.
27. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441: 1068-1074.
28. Le Douarin N, Fontaine J, Le Lievre C. New studies on the neural crest origin of the avian ultimobranchial glandular cells-interspecific combinations and cytochemical characterization of C cells based on the uptake of biogenic amine precursors. Histochemistry 1974; 38: 297-305.
29. Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet 2003; 63: 445-455.
30. Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid 2009; 19: 1303-1315.
31. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004; 25: 722-746.
32. Fagman H, Nilsson M. Morphogenetics of early thyroid development. J Mol Endocrinol 2011; 46: R33-R42.
33. Antonica F, Kasprzyk DF, Opitz R, Iacovino M, Liao XH, Dumitrescu AM et al. Generation of functional thyroid from embryonic stem cells. Nature 2012; 491: 66-71.
34. Longmire TA, Ikonomou L, Hawkins F, Christodoulou C, Cao Y, Jean JC et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 2012; 10: 398-411.
35. Davies TF, Latif R, Minsky NC, Ma R. Clinical review: the emerging cell biology of thyroid stem cells. J Clin Endocrinol Metab 2011; 96: 2692-2702.
36. Lin RY, Kubo A, Keller GM, Davies TF. Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology 2003; 144: 2644-2649.
37. Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun 2009; 381: 264-270.
38. Ma R, Latif R, Davies TF. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells. Thyroid 2013; 23: 385-391.
39. Green MD, Chen A, Nostro MC, d'Souza SL, Schaniel C, Lemischka IR et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol 2011; 29: 267-272.
40. Hannan NR, Fordham RP, Syed YA, Moignard V, Berry A, Bautista R et al. Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Reports 2013; 1: 293-306.
41. Brafman DA, Moya N, Allen-Soltero S, Fellner T, Robinson M, McMillen ZL et al. Analysis of SOX2-expressing cell populations derived from human pluripotent stem cells. Stem Cell Reports 2013; 1: 464-478.
42. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005; 23: 1534-1541.
43. Onyshchenko MI, Panyutin IG, Panyutin IV, Neumann RD. Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells. Stem Cells Int 2012; 2012: 634914.
44. Burstein DE, Nagi C, Wang BY, Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 2004; 35: 465-473.
45. Kusakabe T, Hoshi N, Kimura S. Origin of the ultimobranchial body cyst: T/ebp/Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid. Dev Dyn 2006; 235: 1300-1309.
46. Ozaki T, Nagashima K, Kusakabe T, Kakudo K, Kimura S. Development of thyroid gland and ultimobranchial body cyst is independent of p63. Lab Invest 2011; 91: 138-146.
47. Cameselle-Teijeiro J, Preto A, Soares P, Sobrinho-Simoes M. A stem cell role for thyroid solid cell nests. Hum Pathol 2005; 36: 590-591.
48. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P et al. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 2004; 17: 819-826.
49. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simoes M. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 2003; 16: 43-48.
50. Rios Moreno MJ, Galera-Ruiz H, De Miguel M, Lopez MI, Illanes M, Galera-Davidson H. Inmunohistochemical profile of solid cell nest of thyroid gland. Endocrine Pathol 2011; 22: 35-39.
51. Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S. Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration. Plos One 2013; 8: e80801.
52. Ozaki T, Matsubara T, Seo D, Okamoto M, Nagashima K, Sasaki Y et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology 2012; 153: 2514-2525.
53. Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 2006; 16: 537-544.
54. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol 2008; 198: 471-487.
55. Lan L, Cui D, Nowka K, Derwahl M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab 2007; 92: 3681-3688.
56. Visvader JE. Cells of origin in cancer. Nature 2011; 469: 314-322.
57. Visvader JE, Lindeman GJ. Stem cells and cancer - the promise and puzzles. Mol Oncol 2010; 4: 369-372.
58. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 2011; 108: 7950-7955.
59. Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011; 9: 357-365.
60. Zeuner A, De Maria R. Not so lonely at the top for cancer stem cells. Cell Stem Cell 2011; 9: 289-290.
61. Shahriyari L, Komarova NL. Symmetric vs. asymmetric stem cell divisions: an adaptation against cancer? Plos One 2013; 8: e76195.
62. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 2008; 93: 4331-4341.
63. Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res 2010; 70: 8874-8885.
64. Li W, Reeb AN, Sewell WA, Elhomsy G, Lin RY. Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells. Plos One 2013; 8: e65095.
65. Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J Clin Endocrinol Metab 2014; 99: 536-544.
66. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18: 460-466.
67. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer research 2006; 66: 9339-9344.
68. Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011; 10: 1378-1384.
69. Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, Rodolico V et al. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Thyroid 2013; 23: 829-837.
70. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005; 280: 24731-24737.
71. Friedman S, Lu M, Schultz A, Thomas D, Lin RY. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. Plos One 2009; 4: e5395.
72. Zheng X, Cui D, Xu S. Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol 2010; 37: 307-315.
73. Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW et al. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133 + cells. J Pharmacol Exp Ther 2012; 341: 410-423.
74. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007; 148: 1797-1803.
75. Malaguarnera R, Frasca F, Garozzo A, Giani F, Pandini G, Vella V et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab 2011; 96: 766-774.
76. Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A et al. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. Plos One 2008; 3: e3544.
77. Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM et al. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur J Nucl Med Mol Imaging 2013; 40: 61-71.
78. Liu J, Brown RE. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp Pathol 2010; 3: 755-762.
79. Sun Y, Kong W, Falk A, Hu J, Zhou L, Pollard S et al. CD133 (prominin) negative human neural stem cells are clonogenic and tripotent. Plos One 2009; 4: e5498.
80. Golebiewska A, Brons NH, Bjerkvig R, Niclou SP. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 2011; 8: 136-147.
81. Hollier BG, Evans K, Mani SA. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 2009; 14: 29-43.
82. Raimondi C, Gianni W, Cortesi E, Gazzaniga P. Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Curr Cancer Drug Targets 2010; 10: 496-508.
83. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.
84. Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo LL et al. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 2013; 43: 113-120.
85. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
86. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res 2012; 18: 645-653.
87. Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA. ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res 2011; 17: 5850-5857.
88. Cassinelli G, Favini E, Degl'Innocenti D, Salvi A, De Petro G, Pierotti MA et al. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation. Neoplasia 2009; 11: 10-21.
89. Hardy RG, Vicente-Duenas C, Gonzalez-Herrero I, Anderson C, Flores T, Hughes S et al. Snail family transcription factors are implicated in thyroid carcinogenesis. Am J Pathol 2007; 171: 1037-1046.
90. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 2007; 104: 2803-2808.
91. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M et al. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 2009; 69: 8317-8325.
92. Buehler D, Hardin H, Shan W, Montemayor-Garcia C, Rush PS, Asioli S et al. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas. Mod Pathol 2013; 26: 54-61.
93. Kebebew E, Peng M, Treseler PA, Clark OH, Duh QY, Ginzinger D et al. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells. J Clin Endocrinol Metab 2004; 89: 6105-6111.
94. Ciarrocchi A, Piana S, Valcavi R, Gardini G, Casali B. Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells. Eur J Cancer 2011; 47: 934-945.
95. Deleu S, Savonet V, Behrends J, Dumont JE, Maenhaut C. Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas. Exp Cell Res 2002; 279: 62-70.